Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- Psychedelic-assisted therapy
Current status of PAT
- Osgood-Schlatter Disease
Clinical Presentation, Diagnosis, and Treatment
- Cardiovascular Risk in Rheumatoid Arthritis
What is the most dangerous thing for RA?
- Antisense oligonucleotide for severe hypertriglyceridemia
Reduced Incidence of Acute Pancreatitis
- Hereditary Transthyretin Amyloidosis with Polyneuropathy
New Treatment Options for ATTRv-PN
- Type 1 Diabetes: A New Disease-Modifying Treatment Approach
Slowing the loss of β-cell function and delaying the progression of the disease
- Liver Cancer
Artificial Intelligence in Precision Oncology—Opportunities and Challenges
- Acute nonspecific back pain